Logo
  • Value Delivery
  • Expert Services
  • Partners & Targets
  • Case Studies
  • Case Studies
  • Events
  • About Us
    • Meet Annastasiah
    • Testimonials
  • About Us
    • Meet Annastasiah
    • Testimonials
  • Contact Us

Case Studies

Board & Advisory Roles New Company Creation & Program Execution Coalition Formation & Management Population HealthStrategy Setting and Deal Execution Data as a Centralised Platform

Board and Advisory Roles

Trusted technical and business contributor


Coming soon

Coming soon

New Company Creation & Program Execution

Proven technology value creator


Series A Activities

Raised $70M for AI-supported nanotechnology platform for Dx, disease management, therapeutic monitoring, data processing & transmission at point-of-need

  • Led foundational work initiated by two leading global research organizations
  • Recruited six cross-disciplinary faculty members to serve as co-founders
  • Co-developed investment thesis, commercial and partnership strategy
  • Led investor diligence and negotiation efforts
  • Transitioned efforts to program execution in NewCo

Raised $3M for Cancer-specific promoter-based technology that permits exquisitely sensitive non-invasive detection & treatment of metastases (molecular imaging-based companion theranostic)

  • Led aggregation & integration of assets from two universities to create robust IP portfolio
  • Co-developed clinical development plan & strategy to drive fast-proof, early cash
  • Developed product roadmap and market sizing
  • Led diligence including technical, IP, regulatory & reimbursement and competitive intelligence
  • Led negotiations including pre-money valuation & equity distribution among founders, universities & financiers?

Drew Pardoll, MD., PhD

Director of the Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Medicine

“I was highly skeptical about the whole project but Annastasiah, through force of energy and vision, convinced me – and importantly the Hopkins faculty and leadership – that this project could truly transform medical diagnostics. In all her work at Hopkins, Annastasiah worked on behalf of the investigators and the vision to produce tangible results, even when most felt they could not be achieved. These characteristics built a trust and admiration on the part of her faculty that endures to this day”.

Martin P., MD., PhD

Nuclear Medicine and Molecular Imaging, Leading Health System

“It has been great knowing Annastasiah these 17 years, since she was a graduate student. In that time I have had the pleasure of seeing how nimbly she has been able to negotiate different highly technical areas at the interface of biomedical science and business. I remain most impressed by how Annastasiah helped us start our first company, which was a great challenge for us as academics. I’d like to thank her for her reliability, unusually high capacity for hard work, judgment and the sound advice she has continued to provide over the years”.

Coalition Formation and Management

Not-for profit and innovation system convenor & builder


Alliance for Artificial Intelligence in Healthcare (AAIH)

  • Convened 22 member organisations to promote integration and responsible use of AI to improve Healthcare with focus on Precision Health (biomedical discovery, clinical research & data management, diagnostics & medical devices, patient care and population health)
  • Led strategic planning & business development, day to day operations, and external stakeholder interactions through policy and regulatory affairs, technology & standards development, education, business models and capital formation
  • Initiated international network, coordinated programming and educational sessions, and generated industry resources including workshops and submissions to FDA, NIST, USPTO, Office of Science & Technology Policy e.g., Clinical Decision Support Guidance (CDS), Software as Medical Device (SaMD), inaugural AI Enabled IND and NDA, Capitol Hill Advocacy Day
  • Grew organisation to 35 members in 1 year while launching mission-driving committees, establishing co-chair leads, and leading workstream execution
  • Listen to pre-formation podcast
  • Read Post-launch comments

Naheed Kurji

CEO, Cyclica; Executive Officer, AAIH

“I had the privilege of co-founding and working closely with Annastasiah at the AAIH where I also served Board Member, and Executive Officer. During our time together, I was impressed with how well she coordinated amongst various internal and external stakeholders to ideate, implement, and rapidly evolve an organization to become a thought leader for the responsible application of artificial intelligence to the broader healthcare industry. Annastasiah was tireless in her efforts to build the AAIH into the organization that it is today, and her devotion to the cause and resilience in the face of challenges were her strongest attributes. Her peers hold in high regard, her energy is contagious, and her charisma when communicating AAIH is unparalleled“

Alex Zhavoronkov, PhD

Founder and CEO, Insilico Medicine; Co-founder, AAIH

When I proposed the need for an AI consortium to Brandon Allgood in 2017 it was just an idea. But when Annastasiah joined the effort, AAIH was born. She was the first general manager and organizer of this consortium who brought together many competitors and partners, pharma companies, and academics. She introduced the formal structure, defined the goals, set up the committees, and pretty much singlehandedly turned it into a leading industry organization. We pre-launched it together in Basel in September 2018 and then formally launched at MedTech Showcase in January 2019. It was the largest launch event during the JP Morgan with over a thousand preregistered delegates. With an undergrad in chemistry, a PhD in molecular medicine from Johns Hopkins, and years of business development and licensing experience in large and small organizations, Annastasiah was the perfect catalyst for AAIH to come together. Annastasiah understands both the AI and the pharma aspect and knows how to balance the power and make business happen.

Population Health

Socio-behavioral and workplace champion for comprehensive approach to optimize health & well-being


  • Facilitated foundational agreements to set-up a health benefit program to help manage cancer in the workplace; provides resources on cancer prevention, early detection, management and survivorship targeted for employees, supervisors, and managers to enhance communication and optimise productivity when the employee, family member, or co-worker faces a cancer diagnosis
  • Co-developed business case and priority targets to expand offering to self-insured employers and as an add-on service to existing clients
  • Under Johns Hopkins Healthcare Solutions (JHHCS) leadership has grown to cover a significant number of lives, see https://www.healthy.works/workstride/

Mark A. Cochran, PhD

Executive Director, Johns Hopkins Medicine, Johns Hopkins HealthCare Solutions

“Thanks to Annastasiah’s early work, leadership and vision in advancing this program to the marketplace, it is now used by multiple large-employer clients serving more than 100,000 employees and with great reviews”

Data as a Centralised Platform

Champion for data integration, analysis and responsible use for
Precision & Digital Health


  • Served as (co)- producer, contributor and session chair on workshops and programming to address challenges and implications for data synthesis, integration and interrogation across healthcare and consumer data
  • Underscored critical elements for data synthesis, annotation & sharing requirements and infrastructure
  • Initiated network for coordinating and generating industry resources to address data needs and issues
  • Emphasized tenets, inter-dependencies, linkages and insight generation across consumer and healthcare information (discovery, clinical development, patient care, population health and real-world evidence). Emphasized application of AI to generate insights or aid in decision making for:
    • Cancer Management (Multi-disciplinary Care & Co-ordination)
    • Chronic Disease Management & Monitoring
    • Pandemic Preparedness
    • Radiology (Molecular Imaging)
    • Rare Diseases
    • Socio-behavioural (mental and physical health monitoring and implications)

John B. PhD

former Sr Vice President, GSK; AI Drug Discovery Expert; Founding Chairman, AAIH

“I thank Annastasiah for all her efforts since the inception of the Association. It would not be where it is today without her incredible effort and focus. I also add this personal thank you for her patience and agility in dealing with me. I don’t know how she did it but Annastasiah created some semblance of order out of some rather embryonic concepts and images”.

Bob Bollinger, MD

Global Health and Infectious Diseases; Co-Founder eMOCHA

“I have also had many opportunities to witness and benefit from her incredible leadership, strategic vision, passion and professionalism. She has been particularly brilliant at establishing and building highly productive public-private partnerships that require leveraging and balancing complexities and diverse opinions. I have met and worked with many good people over the years. But, her talent, experience and impact have been truly unique. Annastasiah has been essential to the success of many important projects.”

Strategy Setting and Deal Execution

Cross-sector versatile strategist, asset and capabilities hunter, and broker


Strategy Setting Exemplars

Cross-sector growth strategist, problem solver, and integrator

Emerging Technologies

  • Assessed how technology platform developer could retain and monetize resulting "AI-ready data assets” generated on proprietary genomics system & tools

Diagnostics

  • Developed growth strategy based on provider and patient information requirements for a top global diagnostics manufacturer

Therapeutics

  • Established best business case and unmet medical needs for a Biotech company evaluating entry into Infectious Disease sector

Digital Health

  • Developed portfolio of solutions to improve task execution effectiveness and efficiency, and clinical decision-making to drive better patient outcomes for health systems

Population Health

  • Set-up framework for an employer-based health benefit pilot to provide resources and optimise productivity when the employee, family member, or co-worker faces a cancer diagnosis

Partnering and Deal Execution*

Versatile technology, asset and capabilities hunter, business developer and broker across healthcare

Nanoelectronics-Healthcare Collaboration

  • Leveraged human & intellectual assets to broker partnership between IMEC, an internationally renowned research lab in nanoelectronics and digital technologies, and Johns Hopkins
  • Set-up collaboration and framework for a new technology platform for diagnostics
  • Explored additional project scope for medical-grade and consumer wearables

*deal sheet upon request

Johan Van Helleputte

Retired Sr Vice President Strategic Development, IMEC

“I have experienced Annastasiah as a very intelligent, open minded, hardworking, resourceful, results driven and very loyal counterpart and partner. A driving motivation of Annastasiah’s commitment is the societal impact she can have with her work and her deep conviction about the high leveraging effect of combining technologies and models of cooperation, such as nano-electronics researchers, medical researchers and clinicians jointly working on a high medical need solution. She has a natural ability to bring around the table people of very different backgrounds and to enlighten a common enthusiasm and drive. Next to her professional expertise and thoroughness, as a profoundly knowledgeable person, she is also a very kind and stimulating person to work and to discuss with. It is a really nice experience to have her as a partner and engine for a joint project of high value and impact. I always deeply enjoyed working with her."

Philip Goelet, PhD

CEO & President Evobiotics, Acidophil; Partner, Red Abbey Venture Partners

“Annastasiah brings positive and high energy to the projects and organizations she engages with. The diversity of the subject matter to which this drive has been targeted is equally striking. A natural adventure leader.”


Contact Address

Mawambo LLC
100 International Dr. Fl. 23
Baltimore MD 21202

Reach Us

Operations@mawambo.com +1 443-759-3590

Follow Us

twitter linkedin

Copyright © 2020 Mawambo - All Rights Reserved.